A crater from an Israeli airstrike on Jabalia.

Anas al-Shareef/Reuters

1 of 5

What dense area in Gaza was thrown into chaos yesterday, with hundreds of civilian casualties and injuries, following an Israeli airstrike targeting Hamas leaders?

2 of 5

According to F.B.I. director Christopher A. Wray, the recent conflict between Israel and Hamas has heightened the risk for what type of incident in the United States?

The F.B.I. director, Christopher A. Wray, has highlighted an increased risk of attacks against Americans, specifically Jews and Muslims, due to the recent Israel-Hamas conflict. There has been a significant increase in antisemitic acts, reaching "historic levels" since the conflict began; hate-fueled attacks against Muslims and Arabs in the U.S. have also increased significantly.

3 of 5

In a recent court case, the National Association of Realtors (NAR) and several real estate brokerages were found guilty of violating the Sherman Antitrust Act. What action resulted in them being liable for $1.8 billion in damages?

The defendants were accused of inflating commissions by enforcing a rule that required listing agents to offer compensation to buyer's agents, a practice that plaintiffs argued violated the Sherman Antitrust Act.

4 of 5

What major renewable energy project, the largest of its kind and expected to power over 900,000 homes, has been approved by the Biden Administration off the coast of Virginia?

The Coastal Virginia Offshore Wind project, approved by the Biden Administration, is set to be the largest offshore wind farm in the nation. It's part of the administration's goal to install 30 gigawatts of offshore wind power in the United States by 2030. However, the industry faces challenges like rising costs, supply chain delays, and local opposition.

5 of 5

A panel of experts said that Exa-cel, an innovative treatment for sickle cell disease, is ready for clinical use. Why is this treatment considered groundbreaking?

Exa-cel, a groundbreaking treatment for sickle cell disease, has been deemed safe enough for clinical use by a panel of experts. It is expected to get federal approval by December, and could become the first medicine to treat a genetic disease using the CRISPR gene-editing technique. This could potentially open the door for many new treatment options for genetic diseases in the future.